Composition
- Active substance
- sumatriptan succinate
- International name (INN)
- sumatriptan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Sumatriptan Galpharm
- Active substance
- sumatriptan succinate
- Therapeutic area
- Migraine Disorders
- Marketing authorisation holder
- Galpharm Healthcare Ltd.
- Status
- Refused
- Refused
- 9 Feb 2012
- EMA product number
- EMEA/H/C/002140
EMA designations
- Orphan medicine
- No
- Conditional approval
- No
- Biosimilar
- No
- Generic
- Yes
- Accelerated assessment
- No
- Additional monitoring
- No
- Patient safety information
- No